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Metastasis of tumor cells requires rapid, dynamic regulation of cell-surface adhesion receptors important for migration, inva-
sion, extravasation and growth. One group of proteins involved in 
tumor adhesion is the integrins, a family of heterodimeric adhesion 
receptors fundamentally important to mediating cell–cell and cell–
extracellular matrix (ECM) interactions1. In particular, integrin α4β1 
has been implicated in tumor cell invasion and metastasis2,3. Al-
though integrin α4β1 is expressed in a variety of malignancies, such 
as melanoma4,5, and α4β1 expression has been linked to melanoma 
progression6, the mechanism by which tumor cells modulate integrin 
adhesiveness is not fully understood. However, clustering of integ-
rins triggers a cascade of intracellular signalling pathways leading to 
the phosphorylation of cytoplasmic and cytoskeletal substrates, such 
as focal adhesion kinase (FAK), paxillin and p130cas (refs 1, 7–9). 
Furthermore, both p130cas and FAK play a part in integrinmediated 
tumor cell migration10,11, indicating that modifying integrin signal-
ling pathways may stimulate tumor invasion and  metastasis.
Cell-surface proteoglycans are a second group of adhesion recep-
tors that mediate both cell–cell and cell–ECM interactions12. Many 
ECM proteins contain closely spaced proteoglycan- and integrin-
binding domains, indicating that these two distinct types of adhesion 
receptor may generally function in concert to stimulate cytoskeletal 
reorganization, migration and invasion. Of the proteoglycans, MCSP 
is abundantly and ubiquitously expressed on most human mela-
noma cells, whereas its expression is lower on normal melanocytes13. 
MCSP may be involved in the spreading, migration and invasion of 
melanoma cells, as antibodies directed against MCSP inhibit these 
processes in vitro14,15. We have shown previously that MCSP en-
hances α4β1 integrin function
16–19, in part by stimulating signalling 
pathways involving tyrosine kinases17.
Members of the Rho family of GTPases, Rho, Rac and Cdc42, 
regulate cytoskeletal rearrangements, leading to the formation of ac-
tin stress fi bres, lamellipodia and fi lopodia, respectively20,21. The co-
operative signalling of integrin and syndecan proteoglycan that leads 
to the assembly of focal adhesions has been shown to be Rho depen-
dent22. Integrin-β1-mediated signalling has also been linked to cy-
toskeletal rearrangements through functional interactions of Cdc42 
with phosphatidylinositol-3-OH kinase (PI(3)K) and potentially 
FAK23,24, indicating that Rho-family GTPases may be responsible 
for regulating adhesive signals mediated by both integrins and cell-
surface proteoglycans.
Members of the Ack (activated-Cdc42-associated kinase) 
family of non-receptor tyrosine kinases act as potentially impor-
tant links between certain activated Rho-family GTPases (such as 
Cdc42) and signalling pathways. Members of this family interact 
specifi cally with the GTP-bound (active) form of Cdc42 (refs 25, 
26). Ack-1 is homologous to FAK in its kinase and proline-rich do-
mains, as well as to Src in its kinase and Src homology 3 (SH3) do-
mains25, indicating that Ack-1 may interact with, and phosphory-
late, effector proteins similar to those that interact with FAK and 
Src. Ack-2 is a structural variant of Ack-1; it lacks 344 residues 
within the proline-rich carboxy-terminal tail25. Activated Ack-2 co-
precipitates with β1 integrin
27, suggesting a role for this family of 
kinases in modulating cell adhesion.
We show here that clustering of MCSP activates Cdc42 to a 
GTP-bound state. Furthermore, activated MCSP recruits a signal-
ling complex that includes activated Cdc42 and Ack-1. Formation 
of this complex results in recruitment and tyrosine phosphorylation 
of p130cas and subsequently enhances α4β1-integrin-mediated mela-
noma cell spreading.
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Abstract: Melanoma chondroitin sulphate proteoglycan (MCSP) is a cell-surface antigen that has been implicated in the  growth and in-
vasion of melanoma tumors. Although this antigen is expressed early in melanoma progression, its  biological function is unknown. MCSP 
can stimulate the integrin-α4β1-mediated adhesion and spreading of  melanoma cells. Here we show that stimulated MCSP recruits ty-
rosine-phosphorylated p130cas, an adaptor protein  important in tumor cell motility and invasion. MCSP stimulation also results in a pro-
nounced activation and  recruitment of the Rho-family GTPase Cdc42. MCSP-induced spreading of melanoma cells is dependent upon 
active Cdc42, a Cdc42-associated tyrosine kinase (Ack-1) and tyrosine phosphorylation of p130cas. Furthermore,  vectors inhibiting Ack-1 
or Cdc42 expression and/or function abrogate MCSP-induced tyrosine phosphorylation  and recruitment of p130cas. Our fi ndings indicate 
that MCSP may modify tumor growth or invasion by a unique  signal-transduction pathway that links Cdc42 activation to downstream tyro-
sine phosphorylation and subsequent  cytoskeletal reorganization.
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Results 
MCSP clustering induces tyrosine phosphorylation of a p130 
protein. We have shown previously that cooperative stimulation of 
both MCSP and α4β1 integrin induces cell spreading and focal-con-
tact formation in A375SM human melanoma cells17. The cytoskele-
tal rearrangements delineating this morphology were, in part, depen-
dent upon tyrosine kinases, as shown by an inhibition of melanoma 
cell spreading and focal-contact formation upon pretreatment with 
a tyrosine kinase inhibitor, genistein17. Hence, we have now evalu-
ated a role for tyrosine phosphorylation in MCSP-induced signalling 
pathways. Signal transduction was stimulated in A375SM human 
melanoma cells by addition of magnetic beads coated with 9.2.27, a 
monoclonal antibody directed towards the MCSP core protein. MCSP 
and its associated proteins were separated by SDS–polyacrylamide 
gel electrophoresis (SDS–PAGE) and immunoblotted.  Blots probed 
with anti-phosphotyrosine monoclonal antibodies showed a protein 
migrating at relative molecular mass 130,000 (Mr 130K; p130) (Fig-
ure 1a). Tyrosine phosphorylation of p130 was specifi c and occurred 
in a time-dependent manner following MCSP clustering (Figure 1a). 
Furthermore, MCSP-induced phosphorylation of p130 was sensitive 
to genistein (Figure 1b), indicating that p130 tyrosine phosphoryla-
tion may infl uence MCSP-induced signal transduction leading to in-
tegrin-mediated cell spreading. 
MCSP clustering induces p130cas recruitment and phosphor-
ylation.  We then re-immunoprecipitated MCSP-associated pro-
teins with antibodies directed against various proteins of Mr 130K. 
A monoclonal antibody recognizing p130cas immunoprecipitated a 
MCSP-associated protein of Mr 130K (Figure 1c, lane 5). Although 
p130cas did not associate with MCSP in the absence of clustering, 
clustering of MCSP induced both the recruitment and the tyrosine 
phosphorylation of p130cas (Figure 1c, d, lanes 3, 5). Clustering of 
another cell-surface receptor, the class I major histocompatability 
complex (MHC), by an isotype-matched monoclonal antibody did 
not induce p130cas recruitment or tyrosine phosphorylation (Figure 
1c, d, lanes 2, 4). These results indicate that, under these experimen-
tal conditions, recruitment and tyrosine phosphorylation of p130cas 
specifi cally require MCSP stimulation. 
p130cas is required for MCSP-induced α4β1-mediated cell spread-
ing. We next evaluated the requirement for p130cas in MCSP-induced 
melanoma-cell spreading by using a dominant-negative p130cas 
SH3 construct that binds to a proline-rich span in proteins such as 
FAK10. As reported previously, both untransfected and mock-trans-
fected A375SM melanoma cells adhered but did not spread when ei-
ther α4β1 integrin or MCSP was engaged alone on rIIICS- or 9.2.27-
coated plates, respectively (Figure 2a, b, d, e)17. Only when MCSP 
and α4β1 integrin were engaged cooperatively was cell spreading ob-
served (Figure 2c, f). Cells transfected with the dominant-negative 
p130cas SH3 construct were unable to spread on a substrate engaging 
both MCSP and α4β1 integrin (Figure 2g–i). To determine whether 
tyrosine phosphorylation of p130cas was required for MCSP-induced 
cell spreading, we transfected cells with p130cas(ΔSD), a mutated 
p130cas that lacks residues 119–420, which include multiple YXXP 
motifs (single-letter amino-acid code) that function as tyrosine ki-
nase substrates11,28. Cells transfected with p130cas(ΔSD) failed to 
Figure 1 MCSP clustering induces tyrosine phoshorylation of p130cas . NM, im-
munoprecipitation with mouse IgG. a, Clustering of MCSP induces tyrosine phosphor-
ylation of a protein of Mr 130K (p130) in a time-dependent manner. b, MCSP-induced 
tyrosine phosphorylation of p130 is sensitive to the tyrosine kinase inhibitor genistein. 
c, d, MCSP clustering is required for tyrosine phosphorylation (c) and recruitment (d) 
of p130cas. In c, d, lanes 1–3 depict unclustered samples in which cells were initially 
lysed and immunoprecipitated with mouse IgG (NM) or monoclonal antibodies against 
class I MHC or MCSP. Immunoprecipitates were released and re-immunoprecipitated 
with anti-p130cas monoclonal antibody (c, d) and then blotted with antibody against 
phosphorylated tyrosine (c) or p130cas (d). Lanes 4, 5 show cells that were incubated 
with either anti-MHC or anti-MCSP-coated beads to cluster the antigen. Cells were 
then lysed, and MHC- or MCSP-associated proteins were re-immunoprecipitated with 
anti-p130cas monoclonal antibody and then blotted with antibody against phosphory-
lated tyrosine (c) or p130cas (d). PY, phosphorylated tyrosine. 
Figure 2 MCSP-induced α4β1-integrin-dependent cell spreading involves p130cas 
signalling. Untransfected (a–c) or A375SM cells transfected with vector alone (d–
f) or p130cas SH3 vector (g–i) were allowed to adhere and spread for 1 h on plates 
coated with rIIIcs (a, d, g), monoclonal antibody 9.2.27 (b, e, h) or both (c, f, i). The 
arrowheads denote CaptureTec transfectant selection beads bound to cells. Original 
magnifi cation ×40; scale bar represents 5 μm.
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spread on a substrate engaging both MCSP and α4β1 integrin (data 
not shown). Collectively, these data indicate that recruitment and ty-
rosine phosphorylation of p130cas function in mediating MCSP-in-
duced signal-transduction pathways leading to α4β1-integrin-depen-
dent spreading of melanoma cells. 
Cdc42 associates with MCSP upon MCSP clustering. Previous 
studies have localized MCSP to microspikes and fi lopodia of cul-
tured melanoma cells, indicating that MCSP may mediate early 
cell–matrix recognition events important to the process of cell ad-
hesion29. As the Rho-family GTPase Cdc42 stimulates fi lopodia 
formation in fi broblasts21, we next determined whether Cdc42 as-
sociates with MCSP. We incubated A375SM melanoma cells with 
magnetic beads coated with monoclonal antibody 9.2.27 or P4C2 
(anti-α4-integrin antibody), and analysed associated proteins for the 
presence of Cdc42 by immunoblotting. In the absence of adhesion-
receptor clustering, Cdc42 showed a low level of constitutive asso-
ciation with MCSP but not with α4β1 integrin (Figure 3a, lanes 3, 
4). This association was markedly enhanced (about 4.4-fold, as de-
termined by densitometry) upon MCSP clustering (Figure 3a, lane 
7; data not shown). MCSP-associated Cdc42 represents ~59% of 
total cellular Cdc42 (data not shown). Clustering of α4β1 integrin, 
however, did not induce Cdc42 association with the integrin (Fig-
ure 3a, lane 6). We also determined the activation state of Cdc42 
upon MCSP stimulation. Using the PAK binding domain (PBD) of 
PAK3, which binds preferentially to GTP-bound Cdc42 or Rac, we 
found that MCSP stimulation resulted in a rapid and robust activa-
tion of Cdc42 (Figure 3b). Furthermore, MHC stimulation did not 
induce Cdc42 activation (Figure 3b), indicating that MCSP activa-
tion of Cdc42 is specifi c. 
To determine whether Cdc42 infl uences MCSP-induced signal 
transduction leading to α4β1-integrin-dependent cell spreading, we 
transfected cells with expression vector alone or with constructs en-
coding Cdc42 as a dominant-negative (Cdc42(17N)) or constitutively 
active (Cdc42(12V)) enzyme. We assayed transfected cells for cell 
spreading as described above. Unlike both untransfected and mock-
transfected cells, cells transfected with Cdc42(17N) adhered but did 
not spread when both MCSP and α4β1 integrin were engaged (Figure 
3c). Furthermore, melanoma cells transfected with Cdc42(12V) fully 
spread when α4β1 integrin alone was engaged on rIIIcs-coated plates, 
bypassing the requirement for MCSP engagement in inducing α4β1-
integrin-mediated cell spreading (Figure 3d). Together, these data im-
plicate Cdc42 in mediating post-adhesion cytoskeletal changes fol-
lowing engagement of MCSP and α4β1 integrin in A375SM human 
melanoma cells. 
Cdc42(17N) inhibits MCSP-induced p130cas recruitment and 
phosphorylation. To assess the role of Cdc42 in signal transduction 
from MCSP, we studied the effects of mutant Cdc42 constructs on 
MCSP-induced recruitment and tyrosine phosphorylation of p130cas. 
Cells were transfected with either vector alone or Cdc42(17N). 
Transfected cells were incubated with 9.2.27-coated magnetic beads 
to induce tyrosine phosphorylation of p130cas . Melanoma cells ex-
pressing dominant-negative Cdc42 failed to recruit or tyrosine phos-
phorylate p130cas upon MCSP stimulation (as compared with both 
mock-transfected and untransfected cells) (Figure 4a, b). Cells trans-
fected with a constitutively active Cdc42 construct showed enhanced 
p130cas recruitment and subsequent tyrosine phosphorylation upon 
clustering of MCSP (data not shown). Hence, the GTPase Cdc42 
Figure 3 Activated Cdc42 associates with MCSP and induces spreading of melanoma cells. a, Clustering of MCSP specifi cally recruits Cdc42. b, Cdc42 is specifi cally acti-
vated upon stimulation of MCSP, as determined by interaction with PAK binding domain (PBD)-coated beads, which bind preferentially to active Cdc42 or Rac. c, d, Untransfected 
(UT) or vector-transfected (mock) A375SM cells (c, d), or A375SM cells transfected with dominant-negative Cdc42 (Cdc42(17N)) (c) or constitutively active Cdc42 (Cdc42(12V)) 
(d) were allowed to adhere and spread on plates coated with rIIIcs, monoclonal antibody 9.2.27 or both rIIIcs and 9.2.27. *P < 0.001 compared with untransfected cells.
Figure 4 Cdc42 mediates MCSP-induced p130cas recruitment and tyrosine phos-
phorylation. A375SM cells that were untransfected (UT) or transfected with vector 
alone (mock) or dominant-negative Cdc42 (Cdc42(17N)) were incubated with beads 
coated with monoclonal antibody 9.2.27, which induced clustering of MCSP and tyro-
sine phosphorylation (a) and recruitment (b) of p130cas . 
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is involved in activating MCSP induced tyrosine-kinase pathways 
that lead to the recruitment and tyrosine phosphorylation of p130cas . 
Ack-1 associates with MCSP. As association of Cdc42 with MCSP 
induced tyrosine phosphorylation of p130cas, we proposed that acti-
vated Cdc42-associated kinase-1 (Ack-1) might mediate this phos-
phorylation. We lysed A375SM melanoma cells and immunoprecip-
itated proteins by using antibodies directed against MCSP, class I 
MHC or α4β1 integrin under mild detergent conditions. Subsequent 
in vitro kinase assays (performed in the absence of exogenous sub-
strates) showed that neither class I MHC nor α4β1 integrin exhibited 
signifi cant associated kinase activity under these experimental con-
ditions (Figure 5a, lanes 3, 4), but anti-MCSP immunoprecipitates 
yielded a band at an M  value of ~120–130K (Figure 5a, lane 2). To 
identify this protein(s), we sequentially immunodepleted MCSP-as-
sociated proteins by using antibodies that recognize various proteins 
of ~120–130K, such as FAK, p130cas, vinculin and Ack-1.  Immuno-
depleted lysates were then assayed for any remaining MCSP-associ-
ated kinase activity. 
Using this immunodepletion technique, we found that the MCSP-
associated kinase activity was attributable to Ack-1, as only the de-
pletion of Ack-1 completely inhibited the association of the 120–
130K protein(s) with MCSP (Figure 5b, lane 1; data not shown). 
These data indicate that the 120–130K band may represent either 
Ack-1 or a substrate of Ack-1, but not phosphorylated p130cas, as ly-
sates depleted of p130cas still showed signifi cant MCSP-associated 
kinase activity (data not shown). 
To determine whether Ack-1 participates in MCSP-induced sig-
nal transduction leading to integrin-mediated cytoskeletal changes, 
we constructed an Ack-1 antisense expression vector and expressed 
it in A375SM melanoma cells to inhibit Ack-1 protein expression. 
To confi rm that the antisense vector was expressed, we assayed 
Ack1 kinase activity using myelin basic protein (MBP) as an ex-
ogenous substrate (Figure 6a). This assay confi rmed that antisense 
Ack-1 expression inhibits Ack-1 kinase activity. The Ack-1 kinase 
activity in mock-transfected and untransfected cells was unaffected 
(Figure 6b). Melanoma cells expressing the Ack-1 antisense con-
struct adhered, but did not spread, on a substrate engaging both 
α4β1 integrin and MCSP (Figure 6b). These data are consistent with 
a role for Ack-1 in MCSP-induced signalling pathways that stimu-
late cytoskeletal rearrangements. 
Ack-1 mediates MCSP-induced p130cas tyrosine phosphorylation. 
We next determined whether p130cas was a target substrate for Ack-1 
in MCSP-induced signal-transduction pathways. Cells that were un-
transfected, mock transfected or transfected with the Ack-1 antisense 
construct were incubated with magnetic beads coated with monoclo-
nal antibody 9.2.27 to induce p130cas recruitment and tyrosine phos-
Figure 5 Ack-1 kinase activity is associated with MCSP. a, In vitro kinase activity of 
a 120K–130K protein is specifi cally associated with MCSP. b, Immunodepleting Ack-
1 kinase from cell lysates subsequently ablates the 120K–130K MCSP-associated in 
vitro kinase activity. 
Figure 6 Ack-1 kinase induces spreading of melanoma cells and tyrosine phosphorylation of p130cas. a, Expression of Ack-1 antisense vector inhibits Ack1 in vitro kinase 
activity, as determined by phosphorylation of an exogenous substrate, myelin basic protein (MBP). b, Untransfected A375SM cells (UT) or A375SM cells transfected with either 
vector alone (mock) or Ack-1 antisense vector were allowed to adhere and spread on plates coated with rIIIcs, monoclonal antibody 9.2.27, or both. *P < 0.001 compared with un-
transfected cells. c, Untransfected A375SM cells (UT) or A375SM cells transfected with vector alone (mock) or Ack-1 antisense vector were clustered with 9.2.27-coated beads to 
induce tyrosine phosphorylation of p130cas. d, Untransfected A375SM cells (UT) or cells transfected with mock or Ack-1 kinase-dead (kd) vector were clustered with 9.2.27-coated 
beads to induce tyrosine phosphorylation and recruitment of p130cas. 
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phorylation. Melanoma cells expressing Ack-1 antisense constructs 
failed to recruit and tyrosine phosphorylate p130cas upon MCSP clus-
tering (Figure 6c), indicating that p130cas may be a downstream tar-
get of Ack-1. To determine whether the kinase activity of Ack-1 is 
specifi cally required for signalling from MCSP, we transfected mel-
anoma cells with a kinase-dead Ack-1 construct, Ack1(K163A) (Fig-
ure 6d). Cells transfected with this kinase-dead construct failed to ei-
ther recruit or tyrosine phosphorylate p130cas upon MCSP clustering. 
Together, these data illustrate the importance of Ack-1 kinase activity 
in propagating MCSP-induced signal transduction, ultimately lead-
ing to α4β1-integrin-mediated spreading of melanoma cells. 
Discussion 
Our previous studies showed that MCSP stimulates α4β1-integrinme-
diated adhesion and spreading of melanoma cells16–19, in part through 
the involvement of activated tyrosine kinases17. Here, we have shown 
that signalling through MCSP induces the recruitment and tyrosine 
phosphorylation of p130cas. We propose a unique MCSP-induced 
signalling pathway that integrates both activated Cdc42 and Ack-1, 
thereby stimulating the downstream recruitment and tyrosine phos-
phorylation of p130cas . 
Using dominant-negative p130cas constructs, we showed that 
p130cas promotes MCSP-induced α4β1-integrin-mediated cytoskele-
tal rearrangements.  Phosphorylation of p130cas has been implicated 
in integrin-induced signal-transduction pathways; upon integrin en-
gagement, p130cas is tyrosine phosphorylated through interactions of 
FAK/Src with the SH3 domain of p130cas (refs 28, 30, 31). p130cas 
has also been localized to focal adhesions32. Furthermore, p130cas is 
involved both in FAK-mediated migration of CHO cells10 and in pro-
moting integrin-dependent tumor-cell migration and invasion through 
coupling with Crk11. These results indicate that phosphorylation of 
p130cas by multiple tyrosine kinases may be important for tumor in-
vasion and metastasis by regulating cell adhesion and motility. 
Using a metastatic melanoma cell line, we found that MCSP-in-
duced tyrosine phosphorylation of p130cas is dependent on the re-
cruitment and activation of the Rho-family GTPase Cdc42. Although 
Cdc42 is important for stimulating fi lopodia formation and maintain-
ing cell polarity during cell migration21,33, emerging evidence also 
implicates activation of Cdc42 in cellular transformation and tumor 
progression. For instance, Cdc42 activation confers anchorage-inde-
pendent growth of rat fi broblasts and is required for Ras-mediated 
transformation34. Furthermore, activation of Cdc42 promotes integ-
rin-mediated motility and invasion of breast cancer cells23. On the 
basis of our results, we propose that MCSP enhances tumor cell inva-
sion and metastasis by recruiting a signal-transduction complex that 
includes active Cdc42. 
Our data also show that MCSP-induced sequestration of Cdc42 
and tyrosine-phosphorylated p130cas depends upon the activation of 
the kinase Ack-1. Ack-1 and Ack-2 associate with the GTP-bound 
form of Cdc42 (refs 25–27), and GTP-bound Cdc42 activates auto-
phosphorylation of Ack-2 within cells26. It has, therefore, been pro-
posed that GTP-bound Cdc42 mediates the activation of Ack kinases 
by directing their proper cellular localization26. The subcellular lo-
calization of Ack kinases by interactions with GTP-bound Cdc42 
may enhance the ability of these kinases to recruit and/or phosphory-
late target proteins, further propagating signal transduction. 
Although MCSP can induce signals independently of integrin en-
gagement, our data also indicate that the signals stimulated by MCSP 
are closely related and/or intersect integrin-mediated signal-transduc-
tion pathways. For example, tyrosine phosphorylation of p130cas is 
also associated with ligation of β1 integrin
28,30,31,35,36, indicating that 
this adaptor protein may be involved in integrin-mediated adhesion 
and motility. Furthermore, Ack-2 co-precipitates with β1 integrin, and 
activation of Ack-2 is required for its association with this integrin27; 
however, a direct relationship between Ack-2 and downstream inte-
grin targets such as p130cas or FAK has not been established. Nev-
ertheless, it is possible that MCSP-and α4β1integrin-induced signal-
ling pathways may intersect at multiple points. Such intersections 
may help to amplify these signalling pathways at cell–ECM attach-
ment sites, which in turn act to accelerate cytoskeletal reorganiza-
tion, leading to cell spreading, focal-contact formation and fi rm ad-
hesion. Studies in which MCSP-induced signals are evaluated in the 
absence of functional integrin signalling (for example, using domi-
nant-negative FAK) will be important in defi ning specifi c intersec-
tion points between MCSP and integrin signalling pathways. Pres-
ent studies are also focusing on evaluating the potential involvement 
of other Rho-family GTPases (such as Rac1 and RhoA) in MCSP-in-
duced signalling, as the activity of Rho-family GTPases can be coor-
dinated in certain cell types21. 
The structural features of MCSP that stimulate signal transduc-
tion are also being studied. Addition of chondroitin sulphate to the 
MCSP core protein confers on the proteoglycan the ability to interact 
with the C-terminal heparin-binding domain of fi bronectin (and per-
haps other matrix proteins). α4 integrin subunits also bind to chon-
droitin sulphate glycosaminoglycan (CSGAG) through a unique site 
on the integrin subunit, termed SG-1, and this interaction may en-
hance the activation of certain integrins19. CSGAG does not seem 
to be involved in MCSP-induced signal transduction, as both cell 
spreading and signalling are observed following CSGAG removal 
with chondroitinase ABC (J.I., unpublished observations). Instead, 
the data support a direct role for the MCSP core protein in signal 
transduction. Although the MCSP core protein has no apparent cat-
alytic domains, the cytoplasmic tail of MCSP contains three poten-
tial threonine phosphorylation sites37. The importance of these sites 
has not yet been established; however, inhibitors of serine/threonine 
kinases (such as chelerythrine) inhibit MCSP-induced cell spreading 
(J.I., unpublished observations). Collectively, these results indicate 
that distinct structural features of MCSP may function to enhance ad-
hesion of melanoma cells by both activating integrins and stimulat-
ing signalling pathways that lead to cytoskeletal rearrangement. 
MCSP expression in melanoma cells is increased quite early in 
tumor progression13,38, indicating that it may also function in mel-
anoma biology in ways that are related to cell growth and survival. 
For example, antibodies directed against MCSP inhibit anchorage-
independent growth of human melanoma cells and suppress mela-
noma tumor growth in vivo39,40. Expression of NG2, the rat homo-
logue of MCSP, may also increase both the in vivo tumorigenicity 
of melanoma cells in experimental metastasis models and the pro-
liferation of B16 melanoma cells in vitro41. Cdc42 and Ack-2 have 
been linked to the activation of a subfamily of mitogen-activated 
protein kinases, the c-Jun amino-terminal kinases (JNKs), and 
thereby may stimulate gene expression27,42,43. The sequestration/ 
activation of signalling complexes by MCSP may, therefore, stim-
ulate critical signalling pathways important for controlling growth 
and programmed cell death. 
Methods 
Cell culture. 
Highly metastatic A375SM human melanoma cells were selected by in vivo ex-
perimental metastasis assays of parent A375P cells in nude mice and were pro-
vided by I.J. Fidler44. Cells were maintained in Eagle’s minimal essential media 
(EMEM) supplemented with 10% fetal calf serum, 50μgml–1 gentamycin, min-
imal essential media vitamin solution and 1mM sodium pyruvate. These cells 
were routinely used before 15 cell passages. 
Antibodies. 
Monoclonal antibody 9.2.27, directed towards the MCSP core protein, was a gift 
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from R. Reisfeld. The anti-α4-integrin monoclonal antibody P4C2 was provided 
by E. Wayner. Anti-p130cas monoclonal antibody was purchased from Transduc-
tion Laboratories. Anti-Ack-1 polyclonal antibody sc-323 (Santa Cruz Laborato-
ries) was raised against a C-terminal peptide fragment, NLEQAGCHLLGSWG-
PAHHKR (amino acids 1,072–1,091). Anti-Cdc42 monoclonal antibodies were 
obtained from Santa Cruz Laboratories. Monoclonal antibody against MHC 
class I molecules was obtained from Pharmingen. 
Plasmids. 
The full-length Ack-1 sequence was excised from the plasmid pBluescript SK-
Ack-1 by digestion with EcoRI25. The purifi ed fragment was then ligated into 
pBKRSV (Stratagene) digested with EcoRI. The ligated plasmid was then used 
to transform Escherichia coli strain DH5α. The purifi ed plasmid was sequenced 
at the Microchemical Facility of the University of Minnesota to verify antisense 
orientation and was subsequently designated pBKRSV-Ack-1A.S. The pXJHA-
Ack-1(K163A) kinase-inactive Ack-1 construct was a gift from E. Manser. Plas-
mids expressing glutathione-S-transferase (GST)-conjugated PBD were used 
to estimate the levels of Cdc42 activation as described 45. Dominant-negative 
Cdc42 (Cdc42(17N)) and constitutively active Cdc42 (Cdc42(12V)) in pZip 
were gifts from C. Der. The pKHSH3cas construct was generated as described10. 
pcDL-SRα-p130cas(ΔSD) was generated as described28. The p130cas(ΔSD) in-
sert was liberated from the pcDL-SRα vector by SalI/EcoRI digestion and was 
ligated into SalI/EcoRI-digested pBKRSV (Stratagene). The reporter plasmid 
pHook-1 was purchased from Invitrogen. 
Transfections and selection. 
Cells were grown in six-well plates to about 60% confl uency. Cells were then 
transfected with 2μg of the vector of interest along with 1μg pHook selection 
vector using the clonfectin transfection reagent (Clontech). Briefl y, transfection 
media containing 3μg clonfectin and plasmids were mixed in serum-free EMEM 
for 30 min, after which the transfection media were applied to the cells. Trans-
fection media were removed 3 h later and replaced with standard growth media. 
36 h later, melanoma cells were collected with PBS/1mM EDTA and washed 
several times in serum-free EMEM. Cells were then mixed with CaptureTec 
selection beads (Invitrogen) for 30 min at 37°C; the transfected cells were re-
moved through magnetic separation. Selected cells were washed twice in serum-
free media and used immediately in experiments. 
Preparation of recombinant CS1 (rIIIcs). 
Recombinant CS1 (rIIIcs), representing the alternatively spliced type IIICS do-
main of human fi bronectin, was prepared as described below. A plasmid encod-
ing the C-terminal portion of cellular fi bronectin, provided by M.-L. Chu, served 
as a template for amplifi cation by the polymerase chain reaction (PCR). Syn-
thetic oligonucleotides complementary to fi bronectin nucleotides 5,881–5,901 
(5′) and 6,184–6,204 (3′) and containing 5′ BamHI/3′ EcoRI sites were used as 
primers for PCR to generate the DNA encoding the type IIICS α4β1-integrin-
binding sequence. Template DNA and 1μgml–1 primer were mixed with 1×PCR 
reaction buffer containing 1.5 mM MgCl2 and denatured for 5 min at 95°C. PCR 
was performed for 30 cycles of the following sequence: 60 s at 62°C, 90 s at 
72°C, and 60 s at 95°C, followed by a fi nal, 5-min extension at 72°C. The PCR 
product was ligated into the pGEX-2T vector through the EcoRI and BamHI 
sites and verifi ed by sequencing. The resulting plasmid encoding the GST–IIICS 
fusion protein was used to transform E. coli strain BL21(DE3) (Stratagene). 
Overnight cultures were diluted 1:10 in fresh LB media containing 50 μg ml–
1 ampicillin and incubated for 1 h at 37°C. Protein synthesis was induced by the 
addition of isopropyl-β-D-thiogalactoside (IPTG) to 1mM for 2.5 h at 37°C. Fol-
lowing centrifugation, the bacterial pellets were resuspended in 1:200 volume 
cold extraction buffer (PBS, 1% Triton-X100, 0.1% SDS, 10mM EDTA, 1mM 
phenylmethylsulphonyl fl uoride (PMSF), 1mM NEM, plus 20μg ml–1 each of 
antipain, aprotinin and leupeptin) and subjected to brief sonication on ice. The 
insoluble cell debris were removed by centrifugation and the cleared superna-
tant added to a glutathione–Sepharose affi nity column that was equilibrated with 
phosphate buffered saline (PBS). The column was washed with 50 ml 50mM 
Tris HCl, pH 7.4. The GST–IIICS fusion protein was then eluted with 5mM re-
duced glutathione in 50 mM Tris-HCl at pH 7.4. Finally, the eluted protein was 
assayed for purity and molecular weight by SDS–PAGE. 
Cell-spreading assays. 
Cells were collected with PBS/1mM EDTA and washed twice with serum-free 
EMEM. Cells were adjusted to a fi nal concentration of 5×104 cells ml–1 in se-
rum-free EMEM. 5×103 cells were added to each well of 96-well plates coated 
with rIIIcs, monoclonal antibody 9.2.27, or both. The cells were incubated at 
37°C for 60 min and washed gently with serum-free EMEM. Cells were fi xed 
and stained using DiffQuik solutions (Baxter Inc., Miami, FL). Occupied cell 
areas were quantifi ed under a microscope at a magnifi cation of ×40. Cell bor-
ders were traced electronically; the areas were calculated using a Semi Auto-
matic Image Analysis System (Optomax Inc., Hollis, NH). Statistical signifi -
cance was determined using Student’s t-test. 
Cdc42 activity assay. 
GST–PBD beads were prepared as described46,47. Cdc42 activity was assayed as 
described46,47 with minor modifi cations. Briefl y, A375SM cells were collected 
in 3 mM EDTA/PBS and were washed twice in serum-free media and divided 
into equal aliquots, each containing 5×105 cells. MCSP was clustered with an-
tibody-coated magnetic beads as described above. RIPA buffer (500 mM NaCl, 
1% NP-0, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0, 10mM MgCl2, 
1mM PMSF, 1mM NEM, and 0.1mM pervanadate) was added to cell–bead con-
jugates; this step was followed by brief sonication and centrifugation. Lysates 
were normalized for protein content and were added to 20 μg GST–PBD beads, 
then incubated at 4°C with shaking for 30 min. Beads were washed 3–5 times in 
HBS wash buffer (20 mM HEPES, pH 7.5, 120mM NaCl, 1% NP-40, 10 mM 
MgCl2). Samples were reduced and electrophoresed in 15% SDS–PAGE, and vi-
sualized by western blotting using anti-Cdc42 monoclonal antibodies (see text). 
In vitro kinase assays. 
Cells (2×106) were lysed in immunoprecipitation buffer (50 mM Tris-HCl, pH 
7.3, containing 1% Brij 58, 0.15 M NaCl, 2mM MgCl2, 1 mM PMSF, 1 mM 
NEM and 0.1 mM pervanadate). Lysates were precleared and immunoprecipi-
tated for 4 h at 4°C using the appropriate antibodies conjugated to protein-G–
agarose beads. The beads were washed four times with wash buffer (20 mM 
Tris-HCl, pH 8.2, 150 mM NaCl, 2 mM MgCl2, 1 mM PMSF, 1 mM NEM, 0.1 
mM pervanadate and 0.5% Brij 58). The beads were then washed in NH buffer 
(40 mM HEPES, pH 7.2, 150 mM NaCl, 0.1 mM pervanadate). The beads were 
resuspended in NH buffer and incubated for 10 min at room temperature with 
labelling buffer containing 10 mM Tris, pH 7.4, 10 mM MgCl2, 0.1 mM pervan-
adate, 10 μCi [γ-32P]ATP (ICN). When examining phosphorylation of exoge-
nous substrates, we added 10 μg MBP to the labelling buffer. 
Radiolabelled proteins were separated by SDS–PAGE using a 7.5% running 
gel and a 5% stacking gel under reducing conditions and visualized by autora-
diography. 
Co-immunoprecipitation, SDS–PAGE and western blotting. 
Cells (2×106) were incubated with 9.2.27-, P4C2-, or anti-MHC I-coated mag-
netic beads (Dynal) at a ratio of 50 beads per cell for 3–5 min at 37°C. Cell–
bead aggregates were collected on a magnet and lysed for 20 min at 4°C in ly-
sis buffer containing 50 mM Tris-HCl, pH 7.3, 1% Brij 58, 0.15 M NaCl, 1 mM 
PMSF, 1 mM NEM and 1 mM pervanadate. The bead–protein complexes were 
washed with lysis buffer and associated proteins released by brief sonication in 
1% SDS. The solution was diluted in immunoprecipitation buffer containing 1% 
Triton-X100, 0.15 M NaCl, 1 mM PMSF, 1 mM NEM and 1 mM pervanadate. 
The proteins were then immunoprecipitated using various antibodies, separated 
on 7.5% or 15% separating gels with 5% stacking gel, and transferred to Immob-
ilon-P membrane. The membranes were blocked in PBS containing 1.5% BSA 
at 4°C overnight. Membranes were incubated with the appropriate antibodies for 
1 h at room temperature, washed with PBS containing 0.5% Tween20 and incu-
bated with horseradish-peroxidase-conjugated secondary IgG (1:1,000) for 1 h 
at room temperature. The membrane was extensively washed and proteins de-
tected with the enhanced chemiluminescence (ECL) system (Amersham). 
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